Regarding the mechanism of VCP in HCC, VCP can promote HCC progression through the PI3K/AKT/mTOR pathway.46 However, our research shifts the focus to the role of VCP in the TME and its potential in combination therapy, which offers a novel direction. The gene discussed is AKT1; the disease is hepatocellular carcinoma.